Literature DB >> 10865093

Familial frontotemporal dementia with a P301L tau mutation in Japan.

K Kodama1, S Okada, E Iseki, A Kowalska, T Tabira, N Hosoi, N Yamanouchi, S Noda, N Komatsu, M Nakazato, C Kumakiri, M Yazaki, T Sato.   

Abstract

We have reported the family line with frontotemporal dementia (FTD) in Japan. This family line has so far included four patients. Patient II-1 (man) had a 10 year history of slowly progressive personality and behavioral changes and died at the age of 56. His neuropathological examination showed severe atrophy of the bilateral frontal and temporal cortices with neuronal loss, gliosis and superficial spongiosis. Pick bodies were not found. The neuropathological diagnosis was atypical Pick's disease without Pick bodies or Pick-type in FTD. Patient III-2 is patient II-1's oldest daughter and was taken ill with personality change at the age of 52. She died at the age of 68. Patient III-4 is patient II-1's second daughter. Her onset with strange speech and behavior was at the age of 59. Patient III-5 is patient II-1's oldest son. He also had onset with personality change at the age of 54 and had the P301L mutation in tau. In all III generation cases CT/MRI revealed circumscribed frontotemporal atrophy. Patient III-5's PET/SPECT showed signs of hypoperfusion or hypometabolism in the bilateral frontotemporal areas. This is the first report of familial FTD with the P301L mutation in Japan.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10865093     DOI: 10.1016/s0022-510x(00)00288-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

2.  Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?

Authors:  Emilia J Sitek; Ewa Narozanska; Anna Barczak; Barbara Jasinska-Myga; Michał Harciarek; Małgorzata Chodakowska-Zebrowska; Małgorzata Kubiak; Dariusz Wieczorek; Seweryna Konieczna; Rosa Rademakers; Matt Baker; Mariusz Berdynski; Bogna Brockhuis; Maria Barcikowska; Cezary Zekanowski; Kenneth M Heilman; Zbigniew K Wszolek; Jarosław Slawek
Journal:  Neurocase       Date:  2012-11-05       Impact factor: 0.881

3.  Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.

Authors:  P Tacik; M Sanchez-Contreras; M DeTure; M E Murray; R Rademakers; O A Ross; Z K Wszolek; J E Parisi; D S Knopman; R C Petersen; D W Dickson
Journal:  Neuropathol Appl Neurobiol       Date:  2017-03-08       Impact factor: 8.090

4.  Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations.

Authors:  J L Whitwell; C R Jack; B F Boeve; M L Senjem; M Baker; R J Ivnik; D S Knopman; Z K Wszolek; R C Petersen; R Rademakers; K A Josephs
Journal:  Neurology       Date:  2009-09-29       Impact factor: 9.910

Review 5.  Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.

Authors:  B Ghetti; A L Oblak; B F Boeve; K A Johnson; B C Dickerson; M Goedert
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

6.  Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers.

Authors:  Mica T M Clarke; Frédéric St-Onge; Jonathan D Rohrer; Robert Laforce; Jean-Mathieu Beauregard; Martina Bocchetta; Emily Todd; David M Cash
Journal:  Alzheimers Res Ther       Date:  2021-02-10       Impact factor: 6.982

7.  The role of MAPT gene in Chinese dementia patients: a P301L pedigree study and brief literature review.

Authors:  Shuang He; Shuai Chen; Ming-Rong Xia; Zhi-Kun Sun; Yue Huang; Jie-Wen Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-18       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.